about
Clinical implication of human leukocyte antigen (HLA)-F expression in breast cancerRole of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancerUpdate 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter A: Surgery, Pathology and Prognostic Factors, Adjuvant and Neoadjuvant Therapy, Adjuvant RadiotherapyMagnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal modelsDisease Management Project Breast Cancer in Hesse - 5-Year Survival Data: Successful Model of Intersectoral Communication for Quality Assurance.Interrogating a multifactorial model of breast conserving therapy with clinical data.Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients.Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000.Organizing medical oncology care at a regional level and its subsequent impact on the quality of early breast cancer management: a before-after studySurgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signalingGlibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231.In vivo MRI of early stage mammary cancers and the normal mouse mammary glandLow expression of TFPI-2 associated with poor survival outcome in patients with breast cancerThe EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical DecisionsDevelopment of the Psychosocial Distress Questionnaire-Breast Cancer (PDQ-BC): a breast cancer-specific screening instrument for psychosocial problems.Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.Elevation of SIPL1 (SHARPIN) Increases Breast Cancer RiskRadiation therapy in early-stage invasive breast cancer.Fracture risk and adjuvant therapies in young breast cancer patients: a population-based study.Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome.Molecular imaging in tracking tumor stem-like cellsHereditary breast-ovarian cancer syndrome in Russia.Biological Impact of Pd (II) Complexes: Synthesis, Spectral Characterization, In Vitro Anticancer, CT-DNA Binding, and Antioxidant ActivitiesMetformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.Chemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patientsPhase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancerOxidative stress and its relationship with adenosine deaminase activity in various stages of breast cancer.High throughput screening of cytokines, chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery.Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysisHER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients.Association of HER2 Overexpression and Prognosis in Small (T1N0) Primary Breast CancersOcular surface and tear film abnormalities in women under adjuvant chemotherapy for breast cancer with the 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) regimen.Semi-mechanistic population pharmacokinetic model of multivalent trastuzumab emtansine in patients with metastatic breast cancer.Recent perspectives of breast cancer prognosis and predictive factors.A Comparative Performance Analysis of Multispectral and RGB Imaging on HER2 Status Evaluation for the Prediction of Breast Cancer Prognosis.Association between depressive disorders and risk of breast cancer recurrence after curative surgery.Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting.True local recurrences do not metastasize.Breast cancer stem cells: treatment resistance and therapeutic opportunities.
P2860
Update Breast Cancer 2019 Part 1 - Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast CancerTaxane & cyclophosphamide vs anthracycline & taxane-based chemotherapy as adjuvant treatment for breast cancer: a pooled analysis of randomized controlled trials by the Hellenic Academy of OncologyCompliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional studyAssociation of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer
P921
Q28266906-ECCD2C95-5DD8-4BBA-8729-13CB616A9FE4Q28273513-9819043C-CDCA-4C00-8F9F-2423CDA3CEAFQ30318610-4CBB3791-E114-4BEC-A5D7-81454609D771Q30527961-9ABD5C7F-4147-47F7-B403-B15C4F203CF4Q30828007-C2C24B82-274F-4637-BB59-23FB0E50885AQ30938752-1E48E801-3834-4BDA-A1A9-D9A7A10BC258Q33679736-6A8831B2-E56C-4A39-A96B-3401F87CE2A4Q33858930-2DCC84D4-22B1-409E-A182-CE543A4ACFB5Q34000716-6ABEF15C-8F3A-4FB8-AFC6-8C66184D7C96Q34227685-96CD9F03-DC2D-4344-9A90-AF9A5832D2A0Q34545864-2CD6117F-5AAC-439F-AB3E-AF19A0F09662Q34610711-E732523F-1F8E-4E5F-979B-B680D011BD70Q34623032-7DBF9881-3A93-432B-9461-55D8201FC96AQ34797928-3A9EEA77-85DC-4EC4-9181-5462C6702EB2Q35195209-6A629F0B-F740-4EB7-8019-C8BC731E5B4AQ35585074-E522CAB9-3D64-40C8-807E-D7FF5C7698F3Q35625533-7509C6A8-0EAC-43F0-A6D5-65373CDA2662Q35628076-2DB14C7B-C5DA-40C2-889E-F4C42010F490Q35673226-F09590CD-A11D-47EE-BE65-818A736B9D93Q35849038-B647E206-292B-46E1-A071-1EB41378F845Q35909465-079A111D-ED34-4523-B444-B6A39DD09A5BQ35944416-6ABE4C0C-2F55-463E-A817-A16FF06755FBQ35962049-032F39CC-E72C-40A8-8FE2-EE8610318BAFQ36070998-F6BAAD68-D2CD-4D47-BB83-71A48B5B221BQ36105964-67DF76CD-EE89-4587-A618-DF5295F482A1Q36177752-F7FA26C6-4D76-4A67-A3FC-66B2938D0AC9Q36508067-042FCF4C-E7B8-411C-990D-44CE07963A75Q36540821-CAA2D947-AA64-4D84-9F95-8DC5C2060521Q36557288-518FA0C5-3426-4A9D-8152-D758DD3CAB9BQ36762888-BACC7AD0-A3B1-4275-906A-A3BF9A731B6BQ36766067-66E13210-A5F9-4FD4-9374-3241E120DEB4Q37057992-FAEFADC2-2234-4FE8-B9D9-47740FC45E7EQ37095686-07563067-DAE7-460B-A1A4-C65785E8D766Q37100575-C7FD5144-4B93-4AFF-9E55-4C501E80092CQ37407119-C7983FDB-FA25-4FE8-A278-AB5DD3762D2BQ37414060-CFB9E5A2-0FE2-4582-8AE0-AF609F1A1C05Q37726720-5AB80EB6-74D0-4E3C-AF23-D237B11B2AC8Q37827751-A0EBD948-9B1C-4323-9FDD-9FEAEAF0DA28Q37832441-E0060587-9E4C-4071-A110-A614443486D2Q37839530-68279806-74AE-48C9-9A9F-1B0762ADA726
P2860
description
article publié dans la revue scientifique The Lancet
@fr
im April 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2009
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Early breast cancer
@en
Early breast cancer
@nl
type
label
Early breast cancer
@en
Early breast cancer
@nl
prefLabel
Early breast cancer
@en
Early breast cancer
@nl
P2093
P1433
P1476
Early breast cancer
@en
P2093
Andreas Makris
Ismail Jatoi
John R Benson
Martin Keisch
V Craig Jordan
P304
P356
10.1016/S0140-6736(09)60316-0
P407
P577
2009-04-01T00:00:00Z